Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Mackay (Southampton, United Kingdom), H. Clark (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), A. James ( Solna , Sweden), M. Kupczyk (Lodz, Poland), S. Dahlén ( Solna , Sweden), P. Howarth ( Solna , Sweden). Serum Surfactant Protein D is decreased by oral steroids in asthma but not COPD. 5037

Member's Comments

No comment yet.

Related content which might interest you: Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD Source: Eur Respir J 2009; 34: 95-102 Year: 2009 Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma Source: Eur Respir J 2011; 37: 1366-1370 Year: 2011 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Correlation between plasma levels of IL-33 and Vitamin D in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Serum Vitamin D levels in patients with allergic rhinitis and fungal sensitisation Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Surfactant protein-A serum level is associated with disease control and hospitalisation in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Serum leptin levels in asthmatic children treated with inhaled corticosteroid Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Serum soluble ST2 is corticosteroid sensitive in asthma Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 Level of vitamin D is decreased in asthmatic patients Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Relationship between vitamin A and inflammation in the sputum and serum of smokers and COPD patients Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008